The Relative Strength Index (RSI) is a technical indicator used in the analysis of financial markets. It is intended to chart the current and historical strength or weakness of a stock or market based on the closing prices of a recent trading period. The indicator should not be confused with relative strength.
The RSI is most typically used on a 14-day timeframe, measured on a scale from 0 to 100, with high and low levels marked at 70 and 30, respectively. Shorter or longer time frames are used for alternately shorter or longer outlooks. More extreme high and low levels—80 and 20, or 90 and 10—occur less frequently but indicate stronger momentum.
Stocks to Watch: Edesa Biotech, Inc.
On Thursday, September 05, 2019, the stock (Edesa Biotech, Inc.) created a change of 45.13 percent and closed its last session of business at $5.98. Edesa Biotech, Inc., belongs to Healthcare sector and Biotechnology industry. The relative strength index of the stock stands 69.98.
Historical Performance Review: To understand the smudge picture investors will must to look a little deeper. The Edesa Biotech, Inc. has shown a five days performance of 76.4% and thirty days performance stands at 29.16%. The stock has shown a ninety days performance of -11.8% and a six months performance stand at -16.94%.
Market Capitalization/Outstanding Shares/Intraday Volume: The company’s Market capitalization is $42.76M with the total Outstanding Shares of 7.15M. Market capitalization refers to the entire dollar market cost of a company’s outstanding shares. Referred to as “market cap,” it is determined by doubling a company’s shares outstanding by the current market price of one share. Outstanding shares refer to a company’s stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s officers and insiders.
The Edesa Biotech, Inc. exchanged hands with 10216781 shares compared to its average daily volume of 165.53K shares. Total volume is the number of shares or deals that point towards the overall activity of a security or market for a given period. Volume is an important indicator in technical analysis as it is used to measure the relative worth of a market move. If the markets make a firm price movement, then the strength of that movement depends on the volume for that period. The higher the volume during the price move, the more significant the progress.
Institutional Ownership/ Insider Ownership: Edesa Biotech, Inc. institutional ownership is held at 25% while insider ownership was 7.5%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. Institutions purchase large blocks of a company’s outstanding shares and can exert considerable influence upon its management.
P/S, P/E, P/C and P/B/ SMA50, SMA 200: The price-to-sales is a valuation ratio that relates a company’s stock price to its revenues. The price-to-sales ratio is a symbol of the value placed on each dollar of a company’s sales or taxes. As of now, EDSA has a P/S, P/E and P/B values of 213.79, 0 and 4.15 respectively. P/E and P/B ratios both are used on a regular basis by the investor to measure the value of the company and to get the right amount of the share.
Its P/Cash valued at 0. The price-to-cash-flow ratio is a stock valuation indicator that measures the value of a stock’s price to its cash flow per share
The stock has observed its SMA50 which is now 18.61%. In looking the SMA 200, we see that the stock has seen an -3.01%.The Company’s net profit margin for the 12-months at 0%. Comparatively, the company has a Gross margin -31%.
Profitability Ratios (ROE, ROA, ROI): Looking into the profitability ratios of EDSA stock, an investor will find its ROE, ROA, ROI standing at -61.5%, -56.8% and -44.9%, respectively. Return on assets (ROA) is a financial ratio that shows the percentage of profit a company earns about its overall resources. A performance measure used to estimate the efficiency of an investment or to compare the ability of some different investments. ROI measures the amount of return on an investment relative to the investment’s cost.
Target Price/Analysts Mean Suggestion: Mostly, a price target is an individual analyst’s expectation on the future price of a security, usually a stock. There may be many price targets for only protection. Analyst’s mean target cost for the company is $2 while analysts mean suggestion is 0.
Beta/Volatility: A beta factor is used to measure the volatility of the stock. A Beta component of the stock stands at 2.13. Beta element is utilized to gauge the unpredictability of the stock. The stock remained 23.19% volatile for the week and 11.24% for the month.